Literature DB >> 12210419

Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong.

Paul K S Chan1, K H Mak, Jo L K Cheung, Nelson L S Tang, Denise P C Chan, K K Lo, Augustine F Cheng.   

Abstract

Previous studies have suggested that a few uncommon human papillomavirus (HPV) genotypes are prevalent in Chinese cervical cancer patients. To elucidate the genotype spectrum of HPVs circulating among Hong Kong Chinese, a cross-sectional study was conducted on 553 women who attended a public sexually transmitted disease clinic. HPV DNA was detected from cervical samples using the polymerase chain reaction, followed by genotype identification based on restriction fragment length polymorphism and direct sequencing. The prevalence of HPV was 30.6% for all types combined, 14.8% for high-risk types, 10.8% for low-risk types, and 7.1% for unknown-risk types. Among the HPV-positive women, 89.9% had single type infections; whereas the other 10.1% harboured more than one HPV type. HPV11 was the most prevalent genotype, detected in 5.1% of subjects; followed by HPV16 (4.9%), HPV58 (4.3%), HPV6 (3.3%), and HPV53 and CP8304 (2.2% each). Other less common genotypes found were HPV18, 33, 39, 61, LVX160, MM4, MM7 (range: 0.7-1.6%); HPV26, 45, 54, 56, 59, and LVX100 (range: 0.4-0.5%); HPV35, 40, 52, 55, 68, MM8, and MM9 (0.2% each). This study shows that HPV58 is the second most common high-risk HPV genotype circulating among Chinese female sexually transmitted disease clinic patients in Hong Kong. This together with previous reports of the high prevalence of HPV58 among Chinese cervical cancer patients accentuate the importance of developing vaccines targeting at this otherwise uncommon genotype. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12210419     DOI: 10.1002/jmv.10189

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development.

Authors:  Jee Eun Rhee; Mi Yeong Shin; Choong Mo Kim; Hye Young Kee; Jae Keun Chung; Sang-Kee Min; Seong-Joon Kim; Dai-Ho Jang; Sung Soon Kim; Byeong-Sun Choi
Journal:  Virol J       Date:  2010-08-25       Impact factor: 4.099

2.  Prevalence and risk factors of Human Papillomavirus (HPV) infection in southern Chinese women - a population-based study.

Authors:  Stephanie Si Liu; Kelvin Yuen Kwong Chan; Rebecca Ching Yu Leung; Karen Kar Loen Chan; Kar Fai Tam; May Hiu Mei Luk; Sue Seen Tsing Lo; Daniel Yee Tak Fong; Annie Nga Yin Cheung; Zhong Qiu Lin; Hextan Yuen Sheung Ngan
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

3.  Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58.

Authors:  Sarah A Brendle; Timothy D Culp; Tatevik R Broutian; Neil D Christensen
Journal:  J Gen Virol       Date:  2010-02-24       Impact factor: 3.891

4.  Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.

Authors:  Thomas O Kohl; Inga I Hitzeroth; Neil D Christensen; Edward P Rybicki
Journal:  BMC Biotechnol       Date:  2007-09-12       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.